Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

Background. The optimal retreatment strategy for chronic hepatitis C virus (HCV) patients who fail directly-acting antiviral agent (DAA)-based treatment is unknown. In this study, we assessed the efficacy and safety of ledipasvir (LDV) and sofosbuvir (SOF) for 12 weeks in HCV genotype-1 (GT-1) patie...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Infect Dis
Huvudupphovsmän: Wilson, Eleanor M., Kattakuzhy, Sarah, Sidharthan, Sreetha, Sims, Zayani, Tang, Lydia, McLaughlin, Mary, Price, Angie, Nelson, Amy, Silk, Rachel, Gross, Chloe, Akoth, Elizabeth, Mo, Hongmei, Subramanian, G. Mani, Pang, Phillip S., McHutchison, John G., Osinusi, Anu, Masur, Henry, Kohli, Anita, Kottilil, Shyam
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2016
Ämnen:
Articles and Commentaries
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706633/
https://ncbi.nlm.nih.gov/pubmed/26521268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ874
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk